Drugmaker Shire said on Tuesday it was seeking to buy Baxalta for $30 billion to forge the leading global specialist in rare diseases.» Read More
There's a world of difference between Americans and the rest of the planet on the question of the government paying for health insurance.
Mark Reilly, former chief of GSK in China, will be deported from the country, avoiding jail time there in a corruption scandal, sources say.
President Barack Obama ordered federal departments to launch a concerted effort to combat the growing health threat of bacteria resistant to antibiotics.
New research has found that unresolved problems at home could result in stress at work.
The company aims to make the apps available by the end of the month.
An erectile dysfunction drug that reduces by half the time patients need to take the pill has been approved by the U.S. Food and Drug Administration.
New York Attorney General Eric Schneiderman's suit against Actavis may have far-reaching implications for other drugmakers.
Once the ailing part of a family business, Singapore-listed Eu Yan Sang International, is in the pink of health.
Many of the attendees at the 3rd Annual Pole Expo are taking the lead of expo founder Fawnia Dietrich and refining their craft as a workout activity.
PreferredOne, the insurer that sold nearly 60 percent of all private health plans on Minnesota's Obamacare exchange, will leave that market.
Top executives of Coca-Cola, Bank of America, Aetna and others will unveil a new initiative in Washington Tuesday at the Bipartisan Policy Center.
President Obama will announce a major surge in aid to fight the Ebola epidemic in West Africa, using U.S. military personnel.
About 115,000 people will lose Obamacare coverage by Sept. 30, and another 336,000 risk losing subsidies, officials said.
Few people account for health care costs when planning their savings. These tips will help keep high doctors' bills at bay.
The U.S. has a strategy on Ebola: Increase aid to West Africa and train U.S. medical workers for volunteer duty in the outbreak zone.
Cognizant is buying privately held health-care IT company Trizetto for $2.7 billion in cash, the company announced on Monday.
A N.J. bank will pay $261,500 to settle claims that female workers were denied the family health insurance coverage that male employees got.
The Argus II Retinal Prosthesis System is the world's first FDA-approved 'bionic' eye, a piece of technology that is helping the blind to see.
JPMorgan's CEO Jamie Dimon finished his radiation and chemotherapy treatment this week, The Wall Street Journal reported.
U.S. regulators are greenlighting a new weight-loss drug called Contrave, the third in a string of approvals for anti-obesity treatments.
Get the best of CNBC in your inbox